Using the analytic hierarchy process to elicit patient preferences: Prioritizing multiple outcome measures of antidepressant drug treatment

Patient

Volumn 5, Issue 4, 2012, Pages 225-237

  Hummel, Marjan J M ^a   Volz, Fabian ^b   Van Manen, Jeannette G ^a   Danner, Marion ^b   Dintsios, Charalabos Markos ^b   Ijzerman, Maarten J ^a   Gerber, Andreas ^b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

Author keywords

Antidepressants; Decision analysis; Depression; Duloxetine; Major depressive disorder; Outcome assessment (health care); Outcomes research; Patient preference; Serotonin uptake inhibitors; Venlafaxine.

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ANALYSIS; ANALYTIC HIERARCHY PROCESS; ARTICLE; CLINICAL ARTICLE; COGNITION; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PATIENT PREFERENCE; PRIORITY JOURNAL; PSYCHIATRIST; REMISSION; SENSITIVITY ANALYSIS; SOCIAL ASPECT; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COGNITION; DECISION SUPPORT TECHNIQUES; DEPRESSIVE DISORDER, MAJOR; GERMANY; HUMANS; INTERPERSONAL RELATIONS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PREFERENCE; PSYCHIATRY; PSYCHOTHERAPY; REMISSION INDUCTION;

EID: 84869171675     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11635240-000000000-00000     Document Type: Article

References (35)

1. Bridges J. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy 2003; 2 (4):213-24
2. Louviere JJ, Lancsar E. Choice experiments in health: the good, the bad, the ugly and toward a brighter future. Health Econ Policy Law 2009; 4 (4):527-46
3. Saaty TL. Highlights and critical points in the theory and application of the analytic hierarchy process. Eur J Oper Res 1994; 74:426-47
4. Dolan JG. Multi-criteria clinical decision support: a primer on the use of multiple-criteria decision-making methods to promote evidence-based, patient-centered healthcare. Patient 2010; 3 (4):229-48
5. Dolan JG, Bordley DR. Individualized patient decision-making using the analytic hierarchy process (AHP): reliability, validity, and clinical usefulness [abstract]. Med Decis Making 1991; 11 (4):322
6. IJzerman M, van Til JA, Bridges JFP. A comparison of analytic hierarchy process and conjoint analysis methods in assessing treatment alternatives for stroke rehabilitation. Patient 2012; 5 (1):45-56
7. Hilgerink MP, Hummel JM, Manohar S, et al. Assessment of the added value of the Twente Photoacoustic Mammo-scope in breast cancer diagnosis. Medical Devices (Auckl) 2011; 4:107-15
8. Liberatore MJ, Nydick RL. The analytic hierarchy process in medical and health care decision making: a literature review. Eur J Oper Res 2008; 189 (1):194-207 (Pubitemid 351232135)
9. Dolan JG, Bordley DR. Diagnostic strategies in the management of acute upper gastrointestinal bleeding: patient and physician preferences. J Gen Intern Med 1993; 8 (10):525-9 (Pubitemid 23312928)
10. Hummel JM, van Rossum W, Verkerke GJ, et al. The effects of team expert choice on group-decision making in collaborative new product development: a pilot study. J Multi-Criteria Decis Anal 2000; 9 (1-3):90-8
11. Bloom BS. Prevalence and economic effects of depression. Manag Care 2004; 13 (6):9-16
12. O'Connor EA, Whitlock EP, Beil TL, et al. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009; 151:793-803
13. Masand PS, Gupta SG. Long-term effects of newer-generation antidepressants: SSRIs, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psych 2002; 14 (3):175-82 (Pubitemid 36172566)
14. Nuevo R, Leighton C, Dunn G, et al. Impact of severity and type of depression on quality of life in cases identified in the community. Psychol Med 2010; 11:1-9
15. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303 (1); 47-53
16. Williams Jr JW, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000; 132 (9):743-56 (Pubitemid 30244176)
17. Cunningham LA. Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Ann Clin Psychiatry 1997; 9 (3):157-64 (Pubitemid 27470387)
18. Brannan SK, Mallinckrodt CH, Brown EB, et al. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 2005; 39 (1):43-53 (Pubitemid 39422285)
19. Hewett K, Chrzanowski W, Schmitz M, et al. Eight-week, placebo-controlled, double-blind comparison of the anti-depressant efficacy and tolerability of bupropion XR and venlafaxine XR. J Psychopharmacol 2009; 23 (5):531-8
20. Smith WT, Glaudin V, Panagides J, et al. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Psychopharmacol Bull 1990; 26 (2):191-6 (Pubitemid 20291874)
21. Cooper-Patrick L, Powe NR, Jenckes MW, et al. Identification of patient attitude and preferences regarding treatment of depression. J Gen Intern Med 1997; 12:431-8 (Pubitemid 27300560)
22. Wittink MN, Cary M, Tenhave T, et al. Towards patient-centered care for depression: conjoint methods to tailor treatment based on preferences. Patient 2010; 3 (3):145-57
23. Dwight-Johnson M, Sherbourne CD, Liao D, et al. Treatment preferences among depressed primary care patients. J Gen Intern Med 2000; 15:527-34
24. Danner M, Hummel JM, Volz F, et al. Integrating patients' views into health technology assessment: analytic hierarchy process (AHP) as a method to elicit patient preferences. Int J Technol Assess Health Care 2011; 27 (4):1-7
25. IQWiG. Selective serotonin and norepinephrine reuptake inhibitors (SNRI) for patients with depression: executive summary [IQWiG reports - commission no. A05-20A]. Cologne: IQWi G, 2009 [online]. Available from URL: https://www.iqwig.de/download/A05-20A-Executive-Sum mary-SNRI-for-patients-with- depression.pdf [Accessed 2012 Jun 11]
26. IQWiG. Bupropion, mirtazapine, and reboxetine in the treatment of depression: executive summary [IQWiG reports - commission no. A05-20C]. Cologne: IQWi G, 2009 [online]. Available from URL: https://www.iqwig.de/download/A05- 20C-Executive-summary-preliminary-report-Bupropion-mirtazapine-and-reboxetine- in-the-treatment-of-depression.pdf [Accessed 2012 Jun 11]
27. Triantaphyllou E, Lootsma FA, Pardalos PM, et al. On the evaluation and application of different scales for quantifying pairwise comparisons in fuzzy sets. J Multi-Criteria Decis Anal 1994; 3 (3):133-55
28. Saaty TL. The analytic hierarchy process: planning, priority setting, resource allocation. New York: McGraw-Hill, 1980
29. Harker PT. Derivatives of the Perron root of a positive reciprocal matrix: with application to the analytic hierarchy process. Appl Math Comput 1997; 22 (2-3):217-32
30. Forman E, Peniwati K. Aggregating individual judgments and priorities with the analytic hierarchy process. Eur J Oper Res 1998; 108:165-9 (Pubitemid 128372596)
31. Mareschal B. Weight stability intervals in multicriteria decision aid. Eur J Oper Res 1988; 33:54-64 (Pubitemid 18546735)
32. Triantaphyllou E, Sanchez A. A sensitivity analysis approach for some deterministic multi-criteria decision making methods. Decision Sci 1997; 28:151-94 (Pubitemid 127070910)
33. Saaty TL, Vargas LG. Decision making with the analytic network process: economic, political, social and technological applications with benefits, opportunities, costs and risks. New York: Springer Science and Business Media, 2006
34. Lancsara E, Louviere J. Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences? Health Econ 2006; 15:797-811 (Pubitemid 44184131)
35. Holder RD. Some comments on the analytic hierarchy process. J Opl Res Soc 1990; 41 (11):1073-6